METASTATIC PROSTATE CARCINOMA
Clinical trials for METASTATIC PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis early-stage trial tested a new drug (AZD8186) combined with chemotherapy (docetaxel) in 23 people with advanced solid tumors that have certain gene mutations (PTEN or PIK3CB). The main goals were to find the best dose and check for side effects. The study was completed, but …
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 10:43 UTC
-
Old worming drug shows promise against tough prostate cancer
Disease control CompletedThis early-stage trial tested a combination of two drugs—enzalutamide, a standard hormone therapy, and niclosamide, a drug usually used for tapeworm infections—in 6 men with castration-resistant prostate cancer that had spread or returned. The goal was to find the safest dose and…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New app helps prostate cancer patients decide on genetic testing
Knowledge-focused CompletedThis study tested a mobile-friendly tool that helps men with prostate cancer learn about genetic testing and decide if they want it. The tool includes educational modules and a way to collect family history. The goal was to see if the tool works well and helps patients make infor…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC